ArticleFrontiers in neurology2025
Stroke in young adults in the Middle East and North Africa region: What is the difference from elsewhere? A report from sixteen centers experiences.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The silent risk: cardiometabolic burden and etiology of young stroke in a South Asian migrant cohort, United Arab Emirates.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stroke at a young age is on the rise globally. The diverse range of underlying etiologies and risk factors for stroke in young adults make it challenging. There are very limited papers in this regard from our Middle East and North Africa (MENA) region. Objectives: Identifying risk factors, etiologies and treatment offered to young stroke patients in the MENA region. Method: A five-year multicenter retrospective study across nine MENA countries (2018-2022) was conducted. Multinomial logistic regression was applied to evaluate associations between vascular risk factors and stroke subtypes (adjusted for age, sex, and country). Results: 16 centers participated including 3,971 patients, 65.5% were male. Hypertension (HTN) was the most common risk factor among all stroke subtypes (38%). Diabetes mellitus (DM) and HTN, were the most frequent risk factors for ischemic stroke (IS) and Intracerebral hemorrhage (ICH). Smoking and HTN were common in subarachnoid hemorrhage (SAH). All patients had either Cerebral Computed topography (CT) angiogram or Carotid Doppler, 32.6% of 67.4% showed positive results. A total of 2,441 (61.9%) patients had Transthoracic Echocardiogram (TTE) and/or Transesophageal Echocardiogram (TEE). 11.2% of the patients showed abnormalities. The antiphospholipid screening tests were done in 31.4% of the patients and were positive only in 3.5%. IS was the most common stroke subtype 63.6%, followed by (ICH) 19.2%. Undetermined etiology (UDE) was the most common underlying etiology of IS in 22.2%. Intravenous thrombolysis therapy (IVT) was given in 8.5% of patients. Mechanical thrombectomy (MT) was performed in 3.7%. Anticoagulation therapy was offered in 20% of patients. Endovascular treatment (EVT) was performed in 5.2% of patients. Surgical intervention including clipping or hemicortectomy or hematoma evacuation was done in 5.6% of patients. Conclusion: This study offers the first regionally coordinated effort to examine the risk factors, and etiologies of stroke in young adults across the (MENA) region. The data clearly reflects not only the high burden of disease but also striking variability in patient profiles and healthcare responses between countries. Emerging non-traditional risk factors, and persistent diagnostic limitations, point to the complexity of tackling stroke in the young. Yet, in this complexity lies opportunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.